NEW YORK, April 23-GeneFormatics and Incyte Genomics will collaborate to probe the function of human proteins, the two companies said today.
Incyte will provide proprietary full-length human protein sequences to GeneFormatics, which will use its own structural proteomics technology to identify the function and structure of these proteins.
Incyte may use this data in its genomics patent filings. Financial details were not disclosed.
The collaboration will help validate GeneFormatics' technology and develop its licensing strategies, said CEO John Chiplin in a statement. The San Diego, Calif.-based company, which is privately held, uses a "functional family" approach to protein annotation that relies on structural and chemical proteomics.